Effects of quercetin and rutin on vascular preparations: A comparison between mechanical and electrophysiological phenomena

European Journal of Nutrition

Volumn 42, Issue 1, 2003, Pages 10-17

  Fusi, Fabio ^a   Saponara, Simona ^a   Pessina, Federica ^a   Gorelli, Beatrice ^a   Sgaragli, Giampietro ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Patch clamp; Quercetin; Rat vascular smooth muscle; Rutin; Wine polyphenols

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL L TYPE; FLAVONOID; NATURAL PRODUCT; PHENYLEPHRINE; POLYPHENOL; QUERCETIN; RUTOSIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; DRUG POTENTIATION; ELECTROPHYSIOLOGY; IC 50; MALE; MECHANICS; NONHUMAN; PATCH CLAMP; RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION; WINE;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; AORTA; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS, L-TYPE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; MALE; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; QUERCETIN; RATS; RATS, WISTAR; RUTIN; VASODILATION; VASODILATOR AGENTS;

ANIMALIA;

EID: 0037222007     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-003-0395-5     Document Type: Article

References (35)

1. Valoti M, Sipe Jr HJ, Sgaragli G, Mason RP (1989) Free radical intermediates during peroxidase oxidation of 2-t-butyl-4-methoxyphenol, 2,6-di-t-butyl-4-methylphenol, and related phenol compounds. Arch Biochem Biophys 269:423-432
2. Sgaragli GP, Valoti M, Gorelli B, Fusi F, Palmi M, Mantovani P (1993) Calcium antagonist and antiperoxidant properties of some hindered phenols. Br J Pharmacol 110:369-377
3. Fusi F, Gorelli B, Valoti M, Marazova K Sgaragli GP (1998a) Effects of 2,5-di-t-butyl-1,4-benzohydroquinone (BHQ) on rat aorta smooth muscle. Eur J Pharmacol 346:237-243
4. Fusi F, Gorelli B, Valoti M, Marazova K, Sgaragli GP (1998b) Myorelaxant activity of 2-t-butyl-4-methoxyphenol (BHA) in guinea pig gastric fundus. Eur J Pharmacol 360:43-50
5. Fusi F, Marazova K, Pessina F, Gorelli B, Valoti M, Frosini M, Sgaragli GP (2000) On the mechanisms of the antispasmodic action of some hindered phenols in rat aorta rings. Eur J Pharmacol 394:109-115
6. 2+ current of guinea pig gastric fundus smooth muscle cells. Br J Pharmacol 132:1326-1332
7. 2+ channel via superoxide anion generation. Br J Pharmacol 133:988-996
8. Duarte J, Perez-Vizcaino F, Utrilla P, Jimenez J, Tamargo J, Zarzuelo A (1993a) Vasodilatory effects of flavonoids in rat aorta smooth muscle. Structure-activity relationships. Gen Pharmacol 24:857-862
9. Duarte J, Pérez-Vizcagno F, Zarzuelo A, Jiménez J, Tamargo J (1993b) Vasodilator effect of quercetin in isolated rat vascular smooth muscle. Eur J Pharmacol 239:1-7
10. Herrera MD, Zarzuelo A, Jimenez J, Marhuenda E, Duarte J (1996) Effects of flavonoids on rat aorta smooth muscle contractility: structure-activity relationships. Gen Pharmacol 27:273-277
11. Andriambeloson E, Stoclet JC, Andriantsitohaina R (1999) Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine poliphenols in rat thoracic aorta. J Cardiovasc Pharmacol 33:248-254
12. Formica JV, Regelson W (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33:1061-1080
13. Corder R, Douthwaite JA, Lees DM, Khan NQ, Viseu Dos Santos AC, Wood EG, Carrier MJ (2001) Endothelin-1 synthesis reduced by red wine. Nature 414:863-864
14. Duarte J, Perez-Palencia R, Vargas F, Ocete MA, Perez-Vizcaino F, Zarzuelo A, Tamargo J (2001) Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 133:117-124
15. Diebolt M, Bucher B, Andriantsitohaina R (2001) Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 38:159-165
16. Benito S, Lopez D, Sáiz MP, Buxaderas S, Sánchez J, Puig-Parellada P, Mitjavila MT (2002) A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol 135:910-916
17. Martin S, Andriambeloson E, Takeda K, Andriantsitohaina R (2002) Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Br J Pharmacol 135:1579-1587
18. Chen CK, Pace-Asciak CR (1996) Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 27:363-366
19. Chan EC, Pannangpetch P, Woodman OL (2000) Relaxation to flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure-activity relationships. J Cardiovasc Pharmacol 35:326-333
20. Morales MA, Lozoya X (1994) Calcium-antagonist effects of quercetin on aortic smooth muscle. Planta Med 60:313-317
21. 2+ channels in rat tail artery smooth muscle cells. Br J Pharmacol 135:1819-1827
22. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391:85-100
23. Su CM, Swamy VC, Triggle DJ (1984) Calcium channel activation in vascular smooth muscle by BAY K 8644. Can J Physiol Pharmacol 62:1401-1410
24. Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523-1526
25. Ferriola PC, Cody V, Middleton E Jr (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38:1617-1624
26. Kubota Y, Tanaka N, Umegaki K, Takenaka H, Mizuno H, Nakamura K, Shinozuka K, Kunitomo M (2001) Ginkgo biloba extract-induced relaxation of rat aorta is associated with increase in endothelial intracellular calcium level. Life Sci 69:2327-36
27. Paganga G, Rice-Evans CA (1997) The identification of flavonoids as glycosides in human plasma. FEBS Lett 401:78-82
28. Erlund I, Kosonen T, Alfthan G, Maenpaa J, Perttunen K, Kenraali J, Parantainen J, Aro A (2000) Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 56:545-553
29. Graefe EU, Wittig J, Mueller S, Riethling AK, Uehleke B, Drewelow B, Pforte H, Jacobasch G, Derendorf H, Veit M (2001) Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41:492-499
30. Hollman PC, van Trijp JM, Buysman MN,van der Gaag MS, Mengelers MJ, de Vries JH, Katan MB (1997) Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 418:152-156
31. 2+ fluxes in rat pituitary GH(4)C(1) cells. Eur J Pharmacol 414:125-133
32. Xiong Z, Sperelakis N (1995) Regulation of L-type calcium channels of vascular smooth muscle cells. J Mol Cell Cardiol 27:75-91
33. Usowicz MM, Gigg M, Jones LM, Cheung CW, Hartley SA (1995) Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644. J Pharmacol Exp Ther 275:638-645
34. 2+-induced constriction of the rabbit ear artery. Gen Pharmacol 21:235-239
35. Sen N, Wu A-M, Spitzer AR, Chander A (1997) Activation of protein kinase C by 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-pyridine carboxylic acid methyl ester (Bay K 8644), a calcium channel agonist, in alveolar type II cells. Biochem Pharmacol 53:1307-1313